Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Reviews in Urology|September 21, 2006
Antimuscarinic therapy for the treatment of mixed incontinenceScott MacdiarmidCurrent Medical Research and Opinion|October 4, 2005
Overactive bladder in women: symptom impact and treatment expectationsScott MacDiarmid, Matt RosenbergCurrent Urology Reports|January 24, 2007
Male overactive bladder: the role of urodynamics and anticholinergicsScott MacDiarmid, Alexandra RogersThe Journal of Urology|November 24, 2012
Cost of neuromodulation therapies for overactive bladder: percutaneous tibial nerve stimulation versus sacral nerve stimulationMelissa Martinson, Scott MacDiarmid, Edward BlackUrology|August 1, 2024
Two-year Pivotal Study Analysis of the Safety and Efficacy of Implantable Tibial Nerve Stimulation With eCoin® for Urgency Urinary IncontinenceVincent Lucente, Laura Giusto, Scott MacDiarmidCurrent Urology Reports|October 25, 2008
The effects of reformulation: improved therapeutic indexScott MacDiarmid, Bobby W Sandage, Bimal K MalhotraBJU International|June 8, 2007
The clinical efficacy of tolterodine extended-release is maintained for 24 h in patients with overactive bladderRoger Dmochowski, Karl Kreder, Scott MacDiarmid, et al.International Urology and Nephrology|March 3, 2007
Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trialsRobert B Armstrong, Roger R Dmochowski, Peter K Sand, et al.Journal of Clinical Pharmacology|July 20, 2005
Effect of the proton pump inhibitor omeprazole on the pharmacokinetics of extended-release formulations of oxybutynin and tolterodineRoger Dmochowski, Andrew Chen, Gayatri Sathyan, et al.Advances in Therapy|May 15, 2024
Tibial Nerve Stimulation for Urge Urinary Incontinence and Overactive Bladder: Narrative Review of Randomized Controlled Trials and Applicability to Implantable DevicesUna J Lee, Scott MacDiarmid, Catherine A Matthews, et al.Pageof 4